Subsequently, multiple investigators have taken notice of the oncogenic role of H19; a study revealed that H19 expression was significantly correlated to ER, progesterone receptor, c-erbB-2, and lymph node metastasis in BC patients 105. This evidence concerns the gene H19 and breast cancer.